UNSPSC 51241512: Boric acid/sodium borate/sodium chloride

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP400. This VA Drug Class (OP400) classifies this compound as belonging to the group CONTACT LENS SOLUTIONS.

UNSPSC 51241512 Boric acid/sodium borate/sodium chloride is a Commodity code that nominally covers chemical compounds used in pharmaceutical and industrial applications, but recent state and local procurement under this code actually focuses on establishing multi-source pharmaceutical and over-the-counter product contracts distributed through cooperative purchasing arrangements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, solicits manufacturers to supply generic pharmaceuticals and OTC products meeting specific National Drug Codes and packaging configurations, with vendors required to maintain contractual relationships with authorized wholesalers (AmerisourceBergen Drug Corporation/Cencala, Cardinal Health, and Morris & Dickson Co., LLC) and comply with cGMP standards and Drug Supply Chain Security Act requirements. Products must be available in the marketplace and distributed to participating state and local government facilities by specified effective dates, with evaluation weighted heavily on price competitiveness (75 percent) and secondary criteria including fixed pricing, administrative fee compliance, and EDI capability.

The recent activity under this code centers on cooperative purchasing administered by Minnesota with participation extending to Oregon, representing a multi-state model for pharmaceutical procurement across state and local facilities. The MMCAP RFP (solicitation S1070000015802) issued January 20, 2026, with proposals due March 26, 2026, seeks multiple awards based on therapeutic considerations and member-specific needs; the contract term runs two years for new responders with optional extensions through June 30, 2028 for incumbents. Vendors must carry $5,000,000 commercial general liability insurance, $2,000,000 network security and privacy liability coverage, and $2,000,000 professional liability, and all products must comply with FDA requirements with minimum one-year expiration dates and six-month shelf life from delivery. Performance penalties range from $200 to $1,500 per violation for late reporting, missed onboarding, or improper class-of-trade denials, and vendors pay a 3 percent administrative fee on all contract purchases.